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E-mail address: cao.nguyen@uwa.edu.au (C.D. NguWe introduce a novel method for annotating protein function that combines Naïve Bayes and association
rules, and takes advantage of the underlying topology in protein interaction networks and the structure
of graphs in the Gene Ontology. We apply our method to proteins from the Human Protein Reference
Database (HPRD) and show that, in comparison with other approaches, it predicts protein functions with
signiﬁcantly higher recall with no loss of precision. Speciﬁcally, it achieves 51% precision and 60% recall
versus 45% and 26% for Majority and 24% and 61% for v2-statistics, respectively.
 2011 Elsevier Inc. All rights reserved.1. Introduction a consensus method, GOPred [14] predicted protein function byUnderstanding protein function is one of the most challenging
problems in biology. While many genome sequences have been
generated, a large fraction of the newly discovered genes lack func-
tional characterization. This is particularly true for higher eukary-
otes. While many experimental approaches, including both
individual protein or gene-speciﬁc efforts and large scale, whole-
genome projects, are used successfully, these are time consuming
and expensive. Large scale, computational methods to predict pro-
tein function, therefore, can potentially play important roles.
Early computational methods inferred functions of novel pro-
teins from their amino acid sequence similarity to proteins of
known function [1] or from observations of pairs of interacting
proteins that had orthologs in another organism fused into a single
protein chain [2]. Correlated evolution, correlated RNA expression
patterns, plus patterns of domain fusion, have also been used to
predict similarities in protein functions [3,4]. Several other
approaches have annotated proteins based on phylogenetic proﬁles
of orthologous proteins [5–9]. Bayesian reasoning was used to
combine large-scale yeast two-hybrid (Y2H) screens and multiple
microarray analyses [10] and Support Vector Machines were
used to combine protein sequence and structure data [11] to
produce functional predictions. Other methods related features
extracted from protein 3D structures to function [12,13]. Recently,ll rights reserved.
arch, The Western Australian
yen).combining three different classiﬁers, namely, BLAST k-nearest
neighbor, Subsequence ProﬁleMap and Peptide statistics combined
with support vector machine. While each of these approaches has
had some success, generally they produce high false positive rates
because their underlying principles/assumptions are valid for only
a small number of proteins [15,19]. In addition, many methods
were appropriate largely for prokaryotic sequences [15].
Protein–protein interaction (PPI) data have proven valuable for
inferring protein function from functions of interaction partners.
Facilitating this work, whole genome interaction data have been
and/or are being generated for Escherichia coli, yeast, worm, ﬂy
and human [16–24]. The curated databases consolidate these data-
sets [25–29] that have been used by several methods. The Majority
method annotated yeast proteins based on the most frequent func-
tional properties of nearest neighbors [19]. However, because the
whole network was not considered, a function that occurred at a
very high frequency was not annotated when it did not occur in
the nearest neighbor set. In an approach that extended the Major-
ity method, functions were annotated by exploiting indirect neigh-
bors and using a topological weight [30], and v2-statistics were
used to look at all proteins within a particular radius, although it
did not consider any aspect of the underlying topology of the PPI
network [31]. Functional ﬂow considered each protein as a source
of functional ﬂow for its associated function, which spread through
the neighborhoods of the source [35]. Proteins receiving the high-
est amount of ﬂow of a function were assigned that function. This
algorithm did not take into account the indirect ﬂow of functions
to other proteins after labeling them. Markov random ﬁelds
Fig. 1. A hierarchical structure of GO terms: many-to-many parent–child relation-
ships are allowed in the ontologies. A gene may be annotated to any level of
ontology, and to more than one term within an ontology [45].
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assign protein functions based on a probabilistic analysis of graph
neighborhoods [32–34]. This assumed that the probability distri-
bution for the annotation of any node was conditionally indepen-
dent of all other nodes, given its neighbors. These methods were
sensitive to the neighborhood size and the parameters of the prior
distribution. The MRF methods were later extended by combining
PPI data, with gene expression data, protein motif information,
mutant phenotype data, and protein localization data to specify
which proteins might be active in a given biological process
[36,37]. Other global approaches integrated PPI network with more
heterogeneous data sources (such as large-scale two-hybrid
screens and multiple microarray analyses) [10,38]. Our algorithm
ClusFCM [39] assigned biological homology scores to interacting
proteins and performed agglomerative clustering on the weighted
network to cluster the proteins by known functions and cellular
location; functions then were assigned to proteins by a Fuzzy
Cognitive Map. PRODISTIN formulated a distance function (the
Czekanowski–Dice distance) that uses information on shared inter-
actome to mirror a functional distance between proteins [15].
Other approaches predicted protein functions via the patterns
found among neighbors of proteins within a network [40,41].
Recently, a network-based method combined the likelihood scores
of local classiﬁers with a relaxation labeling technique [42]. Several
approaches applied clustering algorithms to PPI networks to pre-
dict functional modules, protein complexes and protein functions,
however, the performance of these algorithms differs substantially
when run on the same network which leads to uncertainties
regarding the reliability of their results [43].
Here, we extend our previous work [44] by exploring the hier-
archical structure of the Gene Ontology database. For each of pro-
tein, a predicted function will be considered as a true positive if the
function is a parent of any function in the annotated set of the pro-
tein. Thus, this work is a less conservative approach than our pre-
vious work. We use Naïve Bayes combined with association rules
and take into account the underlying topology of a PPI network.
Predicted functions are analyzed by association rules to discover
relationships among the assigned functions, i.e., when one set of
functions occurs in a protein then the protein may be annotated
with an additional set of other speciﬁc functions at some conﬁ-
dence level. We test our method on human protein data and com-
pare its performance with the Majority [19] and v2 statistics [31]
methods.2. Materials
2.1. Gene Ontology (GO) database
The Gene Ontology (GO) [45] was established to provide a com-
mon language to describe aspects of the biology of a gene product.
The use of a consistent vocabulary allows genes from different spe-
cies to be compared based on their GO annotations. GO terms are
composed of the three structured controlled vocabularies (ontolo-
gies): the molecular function of gene products, their associated
biological processes, and their physical location as cellular compo-
nents. Each ontology is constructed as a directed acyclic graph
through a parent–child ‘‘is-a’’ relationship (see Fig. 1). We used
the GO database (version 1.1.940 released 1/2010).2.2. Human interaction dataset
The human interaction data were retrieved from HPRD [29]
(release 7/2009). The entire dataset contains 38,788 direct molec-
ular interactions from three types of experiments (in vivo, in vitro,
and in Y2H). There are 9630 distinct proteins annotated with 433GO functions in the three categories. Because some estimates sug-
gest that more than half of all current Y2H data are spurious
[46,47], we ﬁrst excluded interactions supported only by the Y2H
experiments, leaving 29,557 interactions from in vivo and
in vitro experiments, and 422 GO functions annotating the 7953
unique proteins. A more recent study showed that Y2H data for hu-
man proteins were actually more accurate than literature-curated
interactions supported by a single publication. Therefore, we also
separately analyzed the complete HPRD PPI dataset.
Note that we use the ‘‘is-a’’ relationships to eliminate all parent
GO terms annotated for a protein, i.e. suppose there are two GO
terms A and B annotated for a protein, and if A ‘‘is-a’’ B, then B is
removed from the annotated GO terms of the protein.3. Methods
3.1. Notation
 G = (V, E): an undirected graph to deﬁne the PPI network, where
V is a set of proteins and E is a set of edges connecting proteins u
and v if the corresponding proteins interact physically,
 K: the total number proteins in the PPI network,
 F: the whole GO function collection set and |F|: the cardinality of
the set F,
 fi: a function in the set F (i = 1..|F|),
 O(fi): is the parent ontology set of fi, that is "ge O, fi ‘‘is-a’’ g,
 Cu: the cluster coefﬁcient of protein u,
 Nu: the neighbor set of protein u (proteins interacting directly
with protein u),
 Nfiu: the number of proteins annotated with function fi in Nu and
 Nf iu : the number of proteins un-annotated with function fi in Nu,
where |Nu| = N
fi
u þ Nf iu :
3.2. Posing the problem: from annotation to classiﬁcation
For a function of interest fi, we want to annotate the function fi
to the proteins in a PPI network. We pose the functional annotation
problem as a classiﬁcation problem. The training data are in the
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class information. For each protein u in the network, a function of
interest fi is considered as a class label 1 if the protein u is anno-
tated with fi, and otherwise as 0. The features to deduce class infor-
mation are selected as follows. Exploiting the fact that proteins of
known functions tend to cluster together [19], the ﬁrst feature we
take into account, A1, is the number of proteins annotated with the
function fi in the neighborhood set of protein u (i.e.A1 ¼ Nfiu). The
second feature (A2) is the number of proteins not annotated with
the function fi in the neighborhood set of the protein u (i.e.
A2 ¼ Nf iu ). Several studies indicate that other features can be useful
to predict functions and drug targets for a protein, such as the
number of functions annotated in proteins in the neighborhood
set at level 2 of the protein [31], the connectivity (the total number
of incoming and outgoing arcs of a protein, which is equal to
Nfiu þ Nf iu ), the betweenness (the number of times a node appears
in the shortest path between two other nodes) and the clustering
coefﬁcient Cu (the ratio of the actual number of direct connections
between the neighbors of protein u to the maximum possible num-
ber of such direct arcs between its neighbors) [48]. To select the
best features for a robust learning method, we use a feature selec-
tion method. First, we form a sub set, S, containing two features:
A1 ¼ Nfiu and A2 ¼ Nf iu . Second, we perform a heuristic search by
iteratively adding one feature at a time to the set S (without using
class information) to form a new subset, S0. Next, we classify the
HPRD data with the selected S’ features by the Radial Basis Func-
tion, Support Vector Machine, Logistic Regression and Naïve Bayes.
The feature to be added to S’ is the feature that achieves the max-
imum average value of the harmonic mean of the four classiﬁca-
tion methods. The heuristic search terminates when the average
of the harmonic mean of the four methods does not increase. At
the end of this process we came up with three selected features,
namely, A1 ¼ Nfiu ;A2 ¼ Nf iu and A3 = Cu. We use Weka [49] to imple-
ment the four classiﬁers with default parameters. Performance in
terms of recall, precision, and harmonic mean of the four classiﬁers
on the HPRD data using the three selected features using 10-fold
cross validation is shown in Table 1. Because Naïve Bayes performs
the best in terms of the harmonic mean, we use it in our predictive
modeling.
3.3. Predictive modeling
3.3.1. Phase I: Naïve Bayes
If d = hA1, A2, A3i is an observation for a protein u, we decide a
class membership for the observation d (corresponding to a func-
tion of interest fi) by assigning d to the class with the maximal
probability computed as follows:
lðd; fiÞa argmaxc2f0;1gP^ðcjd; fiÞa argmaxc2f0;1g
P^ðdjc; fiÞP^ðcjfiÞ
P^ðdjfiÞ
ð1Þ
Note thatP(d|fi) can be ignored because it is the same for all classes:
lðd; fiÞ / argmaxc2f0;1gP^ðdjc; fiÞP^ðcjfiÞ ð2Þ
The likelihood P(d|c, fi) is the probability of obtaining the observa-
tion d for a protein u in class c and is calculated as:Table 1
Performance of the radial basic function, support vector machine, logistic regression
and Naïve Bayes methods on the HPRD data set using 10-fold cross validation.
Precision Recall Harmonic Mean
Radial Basis Function 0.63 0.11 0.19
Support Vector Machine 0.81 0.04 0.09
Logistic Regression 0.68 0.15 0.24
Naïve Bayes 0.53 0.27 0.36P^ðdjc; fiÞ ¼ Nfiu þ Nfiu þ Cu
 
!
P^ðA1jc; fiÞN
fi
u
Nfiu !
P^ðA2jc; fiÞN
fi
u
Nfiu !
 P^ðA1jc; fiÞ
Cu
Cu!
ð3Þ
Thus Eq. (2) becomes:
lðd; FiÞ / argmaxc2f0;1g Nfiu þ Nfiu þ Cu
 
!
P^ðA1jc; fiÞN
fi
u
Nfiu !
 P^ðA2jc; fiÞ
N
fi
u
Nfiu !
P^ðA1jc; fiÞCu
Cu!
P^ðCjfiÞ ð4Þ
Because the factorials in Eq. (4) are constant, we can rewrite the
maximum a posteriori class c as follows:
lðd; FiÞ / argmaxc2f0;1gP^ðA1jc; fiÞN
fi
u P^ðA2jc; fiÞN
fi
u P^ðA1jc; fiÞCu P^ðCjfiÞ
ð5Þ
Two key issues arise here. First, the problem of zero counts can
occur when given class and feature values never appear together in
the training data. This can be problematic because the resulting
zero probabilities will eliminate the information from all other
probabilities. We use the Laplace correction to avoid this [50]. Sec-
ond, in Eq. (5), the conditional probabilities are multiplied and this
can result in a ﬂoating point underﬂow. Therefore, it is better to
perform the computations using logarithms of the probabilities.
Eq. (5) then becomes:
lðd; FiÞ / argmaxc2f0;1g exp½Nfiu log P^ðA1jc; fiÞ þ NFiu
 log P^ðA2jc; fiÞ þ Cu log P^ðA3jc; fiÞP^ðc; fiÞ ð6Þ
The parameters of the model, in our case P^ðA1jc; fiÞP^ðA2jc; fiÞP^ðA3jc; fiÞ
and P^ðc; fiÞ can be estimated as follows:
P^ðA1jc ¼ 1; fiÞ ¼
X
Nfiu þ lc1
 
=
X
Nfiu þ Nfiu þ Cu þ lc1
 
ð7Þ
where u e {proteins annotated with fi}
P^ðA1jc ¼ 0; fiÞ ¼
X
Nfiu þ lc1
 
=
X
Nfiu þ Nfiu þ Cu þ lc1
 
ð8Þ
where u e {proteins not annotated with fi}
P^ðc ¼ 1jfiÞ ¼ ðjproteins annotated with f ij þ lciÞ=ðK þ lc2Þ ð9Þ
P^ðc ¼ 0jfiÞ ¼ ðjproteins not annotated withfij þ lciÞ=ðK þ lc2Þ ð10Þ
where lc1 = 1 and lc2 = 2 are the Laplace corrections and the attri-
butes A2 and A3 can be similarly estimated.
3.3.2. Phase II: Association Rules
Association rules are statements of the form {fX} => {fY}, mean-
ing that if we ﬁnd all of {fX} in a protein, we have a good chance
of ﬁnding {fY} with some user-speciﬁed conﬁdence (derived as an
estimate of the probability P({fY}|{fX})) and support (the fraction
of proteins that contain both functions {fX} (in the antecedent)
and {fY} (in the consequent) of the rule in the entire network)
[51]. With 0.1% support and 75% conﬁdence thresholds, we found
900 association rules in the HPRD, and 1154 rules in the HPRD
without Y2H. For example, the rule GO:0004894? GO:0006955
was found with 100% conﬁdence. Next, we derive new functions
from the predicted functions in Phase I by using the mined rules
and the following axioms [52]:
1. if X  Y then X? Y,
2. if X? Y then XZ? YZ for any Z, and
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Fig. 2. Precision and recall results of our method on (a) the HPRD network data and
(b) HPRD without two-hybrid network data.
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Fig. 3. Precision and recall of the three methods on (a) the HPRD network data and
(b) HPRD without two-hybrid network data.
Table 2
Performance of the three methods on two datasets using leave-one-out validation*;
(1): our method (2): majority (3): v2 statistics.
HPRD HPRD without Y2H
(1) (2) (3) (1) (2) (3)
Precision 0.51 0.45 0.24 0.52 0.49 0.23
Recall 0.60 0.26 0.61 0.61 0.28 0.58
MCC 0.55 0.34 0.37 0.56 0.36 0.36
* The selected implicit thresholds for our method, majority, v2 statistics are .3, 3,
and 12, respectively.
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Below we brieﬂy describe the Majority and v2 statistics methods
used in comparisons.
Majority: For each protein u in a PPI network, we count the
number of times each function fi e F occurs in neighbors of the pro-
tein u. The functions with the highest frequencies are assigned to
the query protein u.
v2 statistics: For each function of interest fi we derive the frac-
tion pfi (number of proteins annotated with function fi/K). Then,
we calculate efi as the expected number for a query protein u anno-
tated with fi: efi ¼ Nupfi . The query protein u is annotated with the
function with the highest v2 value among the functions of all pro-
teins in its neighbors, where v2 = ðNfiu  efi Þ2=efi .
The assessment of the proposed method, Majority and v2 statis-
tics, which takes into account the many-to-many relationships of
GO terms, is performed as follows. For a protein, a predicted func-
tion will be (i) a true positive if it exists in the annotated functions
or the set O(annotated functions), and (ii) a false positive if it does
not exists in the annotated set. A function existing in the annotated
set but not existing in the predicted set will be considered as a false
negative while functions in the entire GO set not existing in both
annotated and predicted sets will be true negatives.4. Results and discussions
We implement our method in Java as a combination of Naïve
Bayes and the association rule algorithm. In addition,we implement
theMajority andv2 statisticsmethods and test all on the HPRD data
(with and without interactions identiﬁed by Y2H). To compare the
performance of our method we use implicit thresholds, s We nor-
malize the posterior probability of a query protein u annotatedwith
the function fi: P(c = 1|d, fi) and decide the protein u to be annotated
with the function fi if the normalized P(c = 1|d, fi) > s, where s as-
sumes a value between 0 and 1, in increments of 0.1.
Our method assumes that a newly annotated protein propa-
gates its newly acquired function(s) to its direct neighbors. Thus,
the method is repeated in two iterations. In the second iteration,
to calculate the value A1 ¼ Nfiu for a protein u, we count both the
number of proteins in its neighborhood annotated with fi and pre-
dicted with fi in the ﬁrst iteration. In the Majority and v2 statistics
methods top k functions having the highest scores (k ranges from
0, 1, . . . ,20) are selected and those functions are assigned to the
query protein.
We use the leave-one-out method to evaluate the predictions.
For each query protein u in a PPI network we assume that it is
not annotated. Then, we apply the methods described above to
predict protein functions for protein u. For each method, we choose
the threshold which yields the highest Matthews Correlation Coef-
ﬁcient (MCC) values. Fig. 2 shows the relationship between preci-
sion and recall using different thresholds for the normalized
probabilities of query proteins on the HPRD data sets. The thresh-
old resulting in the highest MCC measures for the HPRD and HPRD
without Y2H data sets is 0.3. Because functional annotations for
proteins are incomplete at present, a protein may have a functionTable 3
Results from one way ANOVA test for MCC value on the two datasets; (1): our method
(2): majority (3): v2 statistics.
HPRD HPRD without Y2H
(1) (2) (3) (1) (2) (3)
Average 0.55 0.34 0.37 0.56 0.36 0.36
Variance 0.07 0.08 0.03 0.07 0.07 0.03
F 1841.2 1581.16
P 0 0
Table 4
Novel protein functions predicted by the Naive Bayes.
HPRD ID Symbol Protein name GO term ID GO name Predicted probability
00010 ACHE Acetylcholinesterase GO:0005201 Extracellular matrix structural constituent 0.99
00010 ACHE Acetylcholinesterase GO:0004872 Receptor activity 0.92
00015 ACTC1 Actin alpha, cardiac muscle GO:0008092 Cytoskeletal protein binding 1.00
00017 ACTG1 Actin gamma 1 GO:0008092 Cytoskeletal protein binding 1.00
00019 ACTN2 Actinin alpha 2 GO:0005194 Cell adhesion molecule activity 0.99
00019 ACTN2 Actinin alpha 2 GO:0005554 Molecular_function 0.96
00021 ACVR1 Activin A receptor, type I GO:0003924 GTPase activity 1.00
00023 PML PML GO:0003700 Transcription factor activity 1.00
00025 ACVR2A Activin A receptor, type II GO:0005102 Receptor binding 1.00
00030 ACTA1 Actin alpha, skeletal muscle 1 GO:0008092 Cytoskeletal protein binding 1.00
00030 ACTA1 Actin alpha, skeletal muscle 1 GO:0005200 Structural constituent of cytoskeleton 1.00
00032 ACTB Actin beta GO:0008092 Cytoskeletal protein binding 1.00
00038 ADA Adenosine deaminase GO:0004930 G-protein coupled receptor activity 0.99
00043 ADORA2A Adenosine A2 receptor GO:0008092 Cytoskeletal protein binding 0.92
00054 ARF1 ADP ribosylation factor 1 GO:0015457 Auxiliary transport protein activity 1.00
00059 FDX1 Adrenodoxin GO:0003824 Catalytic activity 1.00
00061 ADM Adrenomedullin GO:0005179 Hormone activity 0.96
00070 ALDOA Aldolase 1 GO:0003824 Catalytic activity 0.98
00072 A2M Macroglobulin, alpha 2 GO:0008236 Serine-type peptidase activity 0.97
00082 LRPAP1 RAP GO:0004872 Receptor activity 1.00
00097 SAA1 Serum Amyloid A1 GO:0005201 Extracellular matrix structural constituent 1.00
00098 SAA2 Serum amyloid A2 GO:0005201 Extracellular matrix structural constituent 0.97
00101 APCS Serum amyloid P GO:0004872 Receptor activity 0.96
00106 AGT Angiotensin I GO:0008236 Serine-type peptidase activity 1.00
00106 AGT Angiotensin I GO:0004177 Aminopeptidase activity 0.96
00106 AGT Angiotensin I GO:0004180 Carboxypeptidase activity 0.92
00113 CD19 CD19 GO:0004713 Protein-tyrosine kinase activity 1.00
00113 CD19 CD19 GO:0030159 Receptor signaling complex scaffold activity 0.98
00114 CD22 SIGLEC2 GO:0030159 Receptor signaling complex scaffold activity 0.99
00114 CD22 SIGLEC2 GO:0004713 Protein-tyrosine kinase activity 0.95
00116 CD38 Cyclic ADP ribose hydrolase GO:0004872 Receptor activity 0.97
00120 SERPINA3 Alpha 1 antichymotrypsin GO:0008236 Serine-type peptidase activity 1.00
00121 SLPI Secretory leukocyte protease inhibitor GO:0008236 Serine-type peptidase activity 0.98
00123 SLC9A1 Solute carrier family 9, isoform A1 GO:0005509 Calcium ion binding 0.93
00125 CD3EAP Antisense ERCC1 GO:0003899 DNA-directed RNA polymerase activity 0.91
00126 IFNAR1 Interferon, alpha receptor GO:0005125 Cytokine activity 1.00
00133 APOB Apolipoprotein B GO:0003754 Chaperone activity 1.00
00135 APOE Apolipoprotein E GO:0004872 Receptor activity 0.98
00138 LRP1 Low density lipoprotein receptor-related protein 1 GO:0008236 Serine-type peptidase activity 0.98
00139 NR2F2 Nuclear receptor subfamily 2, group F, member 2 GO:0003700 Transcription factor activity 1.00
00139 NR2F2 Nuclear receptor subfamily 2, group F, member 2 GO:0030528 Transcription regulator activity 1.00
00146 ARRB1 Beta arrestin 1 GO:0004930 G-protein coupled receptor activity 1.00
00147 ARRB2 Beta arrestin 2 GO:0004930 G-protein coupled receptor activity 1.00
00120 SERPINA3 Alpha 1 antichymotrypsin GO:0008236 Serine-type peptidase activity 1.00
00121 SLPI Secretory leukocyte protease inhibitor GO:0008236 Serine-type peptidase activity 0.98
00123 SLC9A1 Solute carrier family 9, isoform A1 GO:0005509 Calcium ion binding 0.93
00125 CD3EAP Antisense ERCC1 GO:0003899 DNA-directed RNA polymerase activity 0.91
00126 IFNAR1 Interferon, alpha receptor GO:0005125 Cytokine activity 1.00
00133 APOB Apolipoprotein B GO:0003754 Chaperone activity 1.00
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crease the number of annotated functions that are not predicted
and increase the number of predicted functions that are actually
annotated. The fact that the values of recall are always higher than
the values of precision in all datasets increases conﬁdence in our
method.
The Fig. 3 shows that, for any precision, the recall of our method
outperforms Majority and v2 statistics. Performance measures of
the three methods are shown in Table 2. Our method performs
equally well in both data sets. To gauge the robustness of the
algorithms’ performance (the MCC value), we use the ANOVA one-
way-test for statistical signiﬁcance from the leave one out cross val-
idation. The ANOVA statistics shown in Table 3 conﬁrm that our
method indeed performed better than the compared methods.
In addition to providing statistics tests to cement our method, it
is worth noting that this work takes into account the hierarchical
structure of GO database for predicting functions of a protein. If a
new function of a protein exists in the set O(annotated functions)
of the protein, it will be a true positive. Thus we expect to sacriﬁce
the cost of recall (sensitivity) to increase precision. However, the
performance (i.e. recall and precision) of our method was not sig-niﬁcantly changed in comparison with our previous work. The rea-
son is probably that in comparison with an average of 1.56 (1.77)
shared functions per each interactome, there is only an average
of 0.19 (0.15) functions in the O(annotated functions) per each
interactome in the HPRD (HPRD without Y2H) dataset. Thus, those
functions account for a minor proportion of the performance
measures.
Because protein functional annotation is incomplete, it is possi-
ble that novel predicted functions that are at present false positives
may eventually be discovered to be true positives. We list in Table 4
some proteins from the HPRD without Y2H dataset that are anno-
tated with novel functions at very high probabilities (>.9). The full
list of predicted functions for human proteins and Java source code
are shown in Supplementary Materials at http://chr21.egr.vcu.edu/
bayesian.5. Conclusions
We have described a novel method for protein functional
annotation that combines Naïve Bayes and association rules. The
C.D. Nguyen et al. / Journal of Biomedical Informatics 44 (2011) 824–829 829method used global optimization that took into account the fol-
lowing features of interaction networks: direct and indirect inter-
actions, the underlying topology (cluster coefﬁcients), and
functional protein clustering, as well as the many-to-many rela-
tionships of the GO terms in the GO database. We have shown
the robustness of our method by testing it on two interaction data
sets using the leave-one-out cross-validation. The results showed
that our method consistently outperformed the Majority and the
v2-statistics methods in predicting protein functions. In addition,
our method predicts new relationships among the predicted func-
tions that can provide new experimental directions. Finally, in
comparison with previous work, the results empirically showed
that our approach does not depend on the GO’s hierarchy.
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